跳至主要内容
临床试验/NCT00867256
NCT00867256终止不适用

Large Diameter Metal-on-Metal Total Hip System IDE

Corin0 个研究点目标入组 195 人开始时间: 2004年3月31日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Corin
入组人数
195
主要终点
Composite clinical criterion

研究概览

简要总结

To demonstrate the safety and efficacy of the Cormet Large Diameter Metal on Metal (LDMOM) Total Hip System using a composite clinical success (CCS) primary endpoint.

详细描述

The results from the Cormet Large Diameter Metal on Metal (LDMOM) Total Hip System cohort will be compared to the historical results from a ceramic on ceramic (CoC) hip system cohort. The primary endpoint clinical composite success (CCS) criterion at 24 months postoperative is based on a Harris Hip Score ≥ 80 and the absence of any revision,replacement, or modification of any study component.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • is skeletally mature
  • is mentally capable of completing follow-up forms
  • will be available for follow-up out to 2 years
  • has a preoperative Harris Hip Score <70 points
  • has been deemed a candidate for hip replacement by diagnosis of the investigator.

排除标准

  • has active joint infection
  • has had previous hip arthrodesis (fusion)
  • has had above knee amputation of either extremity
  • has active neoplastic disease
  • has a need for a structural bone graft in the operative side
  • has an ipsilateral hemi or total arthroplasty of any kind
  • has a nonunion or malunion of any part of the femur on operative side
  • has severe osteoporosis of the pelvis and/or femur as noted on standard radiograph
  • is a prisoner
  • is pregnant
  • is known to be allergic to implant materials
  • is morbidly obese.

结局指标

主要结局

Composite clinical criterion

时间窗: 24-months postoperative

Based on Harris Hip Score ≥ 80, and absence of any revision, replacement, or modification of any study component

次要结局

未报告次要终点

研究者

发起方
Corin
申办方类型
Industry
责任方
Sponsor

相似试验